Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    Peptides from common viral and bacterial pathogens can efficiently activate diabetogenic T-cells.

    Judkowski VA, Allicotti GM, Sarvetnick N, Pinilla C.

    Diabetes. 2004 Sep;53(9):2301-9.PMID: 15331539 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.

    Judkowski V, Pinilla C, Schroder K, Tucker L, Sarvetnick N, Wilson DB.

    J Immunol. 2001 Jan 15;166(2):908-17.PMID: 11145667 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.

    You S, Chen C, Lee WH, Wu CH, Judkowski V, Pinilla C, Wilson DB, Liu CP.

    J Immunol. 2003 Apr 15;170(8):4011-20.PMID: 12682229 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.

    Masteller EL, Warner MR, Ferlin W, Judkowski V, Wilson D, Glaichenhaus N, Bluestone JA.

    J Immunol. 2003 Nov 15;171(10):5587-95.PMID: 14607967 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas.

    Dai YD, Jensen KP, Lehuen A, Masteller EL, Bluestone JA, Wilson DB, Sercarz EE.

    J Immunol. 2005 Sep 15;175(6):3621-7.PMID: 16148106 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.

    Chaturvedi P, Agrawal B, Zechel M, Lee-Chan E, Singh B.

    J Immunol. 2000 Jun 15;164(12):6610-20.PMID: 10843721 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes.

    Phillips JM, Parish NM, Drage M, Cooke A.

    J Immunol. 2001 Dec 1;167(11):6087-91.PMID: 11714766 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.

    You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L.

    Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14580-5. Epub 2004 Aug 30.PMID: 15340148 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.

    Mukherjee R, Wagar D, Stephens TA, Lee-Chan E, Singh B.

    J Immunol. 2005 May 1;174(9):5306-15.PMID: 15843527 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.

    Roberts SA, Barbour G, Matarrese MR, Mason DL, Leiter EH, Haskins K, Hanson MS.

    J Autoimmun. 2003 Sep;21(2):139-47.PMID: 12935783 [PubMed - indexed for MEDLINE]Related articles

    13.

    Peptide specific amelioration of T cell mediated pathogenesis in murine type 1 diabetes.

    Judkowski V, Rodriguez E, Pinilla C, Masteller E, Bluestone JA, Sarvetnick N, Wilson DB.

    Clin Immunol. 2004 Oct;113(1):29-37.PMID: 15380527 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

    Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, Lee M, Davis M, McDevitt HO.

    Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14204-9. Epub 2004 Sep 20.PMID: 15381770 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.

    You S, Chen C, Lee WH, Brusko T, Atkinson M, Liu CP.

    J Immunol. 2004 Dec 1;173(11):6777-85.PMID: 15557171 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy.

    Yamamoto AM, Chernajovsky Y, Lepault F, Podhajcer O, Feldmann M, Bach JF, Chatenoud L.

    J Immunol. 2001 Apr 15;166(8):4973-80.PMID: 11290776 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.

    Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC.

    J Immunol. 2004 Mar 15;172(6):3955-62.PMID: 15004204 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.

    Alleva DG, Gaur A, Jin L, Wegmann D, Gottlieb PA, Pahuja A, Johnson EB, Motheral T, Putnam A, Crowe PD, Ling N, Boehme SA, Conlon PJ.

    Diabetes. 2002 Jul;51(7):2126-34.PMID: 12086942 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Identification of peptides from human pathogens able to cross-activate an HIV-1-gag-specific CD4+ T cell clone.

    Venturini S, Allicotti G, Zhao Y, Simon R, Burton DR, Pinilla C, Poignard P.

    Eur J Immunol. 2006 Jan;36(1):27-36.PMID: 16323241 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data